Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADCs
Biotech
Pfizer pulls the plug on 11 programs
Pfizer has axed 11 programs including two pipeline assets from its Seagen buy, work on a BioNTech-partnered mRNA vaccine and a midstage MASH combo.
Gabrielle Masson
Nov 4, 2025 2:40pm
French antibody biotech draws in $122M for push to clinic
Oct 16, 2025 11:19am
Daiichi, Merck rev up for accelerated approval filing
Sep 7, 2025 10:45am
China-based Novatim notches new deal with another US biotech
Sep 2, 2025 2:36pm
ADC biotech adds on $135M series B
Nov 25, 2024 7:00am
Alentis raises $181M series D to bring ADCs to the clinic
Nov 12, 2024 7:00am
